Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 1
1996 1
1997 2
1999 1
2000 1
2001 2
2002 6
2003 6
2004 2
2005 9
2006 2
2007 2
2008 4
2009 4
2010 5
2011 6
2012 7
2013 10
2014 5
2015 6
2016 4
2017 2
2018 2
2019 6
2020 6
2021 7
2022 7
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

102 results
Results by year
Filters applied: . Clear all
Page 1
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy.
Blanco B, Domínguez-Alonso C, Alvarez-Vallina L. Blanco B, et al. Among authors: alvarez vallina l. Clin Cancer Res. 2021 Oct 15;27(20):5457-5464. doi: 10.1158/1078-0432.CCR-20-3770. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108185 Free PMC article. Review.
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.
Tapia-Galisteo A, Sánchez Rodríguez Í, Aguilar-Sopeña O, Harwood SL, Narbona J, Ferreras Gutierrez M, Navarro R, Martín-García L, Corbacho C, Compte M, Lacadena J, Blanco FJ, Chames P, Roda-Navarro P, Álvarez-Vallina L, Sanz L. Tapia-Galisteo A, et al. Among authors: alvarez vallina l. Oncoimmunology. 2022 Feb 7;11(1):2034355. doi: 10.1080/2162402X.2022.2034355. eCollection 2022. Oncoimmunology. 2022. PMID: 35154908 Free PMC article.
The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B, Carretero-Puche C, Gomez-Lopez G, Al-Shahrour F, Riesco MC, Gil-Calderon B, Alvarez-Vallina L, Espinosa-Olarte P, Gomez-Esteves G, Rubio-Cuesta B, Sarmentero J, La Salvia A, Garcia-Carbonero R. Soldevilla B, et al. Among authors: alvarez vallina l. Eur J Cancer. 2019 Dec;123:118-129. doi: 10.1016/j.ejca.2019.09.008. Epub 2019 Nov 1. Eur J Cancer. 2019. PMID: 31678770 Free article.
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
Blanco B, Ramírez-Fernández Á, Bueno C, Argemí-Muntadas L, Fuentes P, Aguilar-Sopeña Ó, Gutierrez-Agüera F, Zanetti SR, Tapia-Galisteo A, Díez-Alonso L, Segura-Tudela A, Castellà M, Marzal B, Betriu S, Harwood SL, Compte M, Lykkemark S, Erce-Llamazares A, Rubio-Pérez L, Jiménez-Reinoso A, Domínguez-Alonso C, Neves M, Morales P, Paz-Artal E, Guedan S, Sanz L, Toribio ML, Roda-Navarro P, Juan M, Menéndez P, Álvarez-Vallina L. Blanco B, et al. Among authors: alvarez vallina l. Cancer Immunol Res. 2022 Apr 1;10(4):498-511. doi: 10.1158/2326-6066.CIR-21-0853. Cancer Immunol Res. 2022. PMID: 35362043 Free PMC article.
Functionally fused antibodies--a novel adjuvant fusion system.
Larsen M, Jensen KB, Christensen PA, Suarez E, Paris D, Sanz L, Ravn P, Sauce D, Saas P, Goletz S, Alvarez-Vallina L, Kristensen P. Larsen M, et al. Among authors: alvarez vallina l. J Immunol Methods. 2008 Dec 31;339(2):220-7. doi: 10.1016/j.jim.2008.09.015. Epub 2008 Oct 12. J Immunol Methods. 2008. PMID: 18854189
Applications of trimerbodies in cancer immunotherapy.
Compte M, Sanz L, Álvarez-Vallina L. Compte M, et al. Among authors: alvarez vallina l. Int Rev Cell Mol Biol. 2022;369:71-87. doi: 10.1016/bs.ircmb.2022.03.008. Epub 2022 May 16. Int Rev Cell Mol Biol. 2022. PMID: 35777865
Engineered mRNA and the Rise of Next-Generation Antibodies.
Sanz L, Álvarez-Vallina L. Sanz L, et al. Among authors: alvarez vallina l. Antibodies (Basel). 2021 Sep 26;10(4):37. doi: 10.3390/antib10040037. Antibodies (Basel). 2021. PMID: 34698057 Free PMC article. Review.
Antibody-based antiangiogenic cancer therapy.
Sanz L, Alvarez-Vallina L. Sanz L, et al. Among authors: alvarez vallina l. Expert Opin Ther Targets. 2005 Dec;9(6):1235-45. doi: 10.1517/14728222.9.6.1235. Expert Opin Ther Targets. 2005. PMID: 16300473 Review.
102 results